Talazoparib drug page Clinical trials

Trials with Talazoparib

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

3Trials
1Recruiting
2Countries
161Planned patients

Showing 1–3 of 3

Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer
Recruiting Phase 2 40 patients NCT05725200

The purpose of the study is to investigate the effect and side effects of personalized cancer treatment in patients with metastatic colorectal cancer (bowel cancer). All patients included must have metastatic bowel cancer and receive or ha…

Norway Sept 2022 – Dec 2040 Interventional
Testing the Combination of the Anti-cancer Drugs ZEN003694 (ZEN-3694) and Talazoparib in Patients With Advanced Solid Tumors, The ComBET Trial
Ongoing, not recruiting Phase 2 88 patients NCT05327010

This phase II trial tests whether ZEN003694 (ZEN-3694) in combination with talazoparib works to shrink tumors in patients with solid tumors that are unlikely to be cured or controlled with treatment and that may have spread from where it f…

United States Nov 2022 – Dec 2027 Interventional
Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors
Finished Phase 1 33 patients NCT03875313

This is a Phase 1b/2 study to determine the recommended phase 2 dose (RP2D), safety and tolerability, pharmacokinetics (PK) and clinical activity of the glutaminase inhibitor CB-839 with the poly adenosine diphosphate ribose polymerase (PA…

United States May 2019 – Jul 2020 Interventional
Combined with: CB-839

Where the recruiting trials are